AdvAnces & controversies in MAlignAnt HeMAtology & oncology

Target AudienceThe CTCA REVIEW will be of interest to healthcare providers involved in the care of oncology patients, including medical oncologists, hematologists, surgical oncologists, radiation oncologists, diagnostic radiologists, pathologists, oncology fellows, resident trainees, primary care providers, advanced care practitioners, physician assistants, nurses, chiropractors, naturopathic physicians, and pharmacists.

Educational Methods• InteractivePresentations• PatientCasePresentations• FacultyPanel• QuestionandAnswerSessions

Course EvaluationA course evaluation form will be provided to CTCA REVIEW participants to have the opportunity to comment on any perceived commercial bias in the presentations, as well as to identify future educational topics. In addition, participants will have the opportunity to comment on the value of the program content on their practice decisions, performance improvement activities, or possible impact on patient health status.

Accreditation/Credit Designation PhysiciansThis activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Dannemiller and Athena Education Group. Dannemiller is accredited by the ACCME to provide continuing medical education for physicians. Dannemiller designates this live activity for a maximum of 8.5 AMAPRACategory1 Credits™.Physiciansshouldclaimonlythecredit commensurate with the extent of their participation in the program.

Registered NursesDannemiller is a provider approved by the California BoardofRegisteredNursing,ProviderNumber4229.This activity has been approved for 8.5 contact hours. PleaseNote:RNsoutsideCaliforniamustverify with their licensing agency for approval of this course.

As a provider accredited by ACCME, Dannemiller must ensure balance, independence, objectivity and scientific rigor in its educational activities. Course director(s), planning committee, faculty, and all others who are in a position to control the

content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter oftheeducationalactivity.Safeguardsagainstcommercialbiashavebeenputinplace.Facultyalso will disclose any off-label and/or investigational use of pharmaceuticals or instruments discussed in their presentation. Disclosure of this information will be published in course materials so those participants in the activity may formulate their own judgment regarding the presentation.

Pharmacists Dannemiller, Inc. is accredited by the AccreditationCouncilforPharmacy Education as a provider of continuing pharmacy education. This activity is a application based activity. Dannemiller has assigned 8.5 contact hours (0.85 CEU) of continuing pharmacyeducationcredittothisactivity.ACPEprogramnumber0522-9999-13-005-L01-P.

CME Certificates and Attendance Verification CertificatesCertificates awarding AMAPRACategory1Credit™ or certificates documenting attendance will be distributed after the meeting. To obtain a CME or CE certificate, healthcare providers must submit a completed evaluation questionnaire and a CME/CE VerificationForm.

Upon request, a record of attendance (certificate) will be provided onsite to other oncology care professionals for requesting credits in accordance with state nursing boards, specialty societies, or other professional associations.

Unapproved Uses of Drugs/DevicesInaccordancewithrequirementsoftheFoodandDrugAdministration(FDA),theaudienceisadvisedthat information presented in this continuing medical education activity may contain references to unlabeled or unapproved uses of drugs or devices.PleaserefertotheFDA-approvedpackageinsert for each drug/device for full prescribing information.

American’s with Disabilities Act (ADA)Dannemiller and Athena fully comply with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, pleasecontactSueatsue@premiermeetingservices.combyJuly1,2013inordertoreceiveappropriateservices at the conference.

Partiallysupportedby Cancer Treatment Centers of America®.

Jointly sponsored by Dannemiller and Athena Education Group.

DannemillerandAthenaEducationGroupgratefullyacknowledgean educational grant from the Cancer Treatment Centers of America® in support of this continuing medical education activity.*This review course is not an official

program of ASH or ASCO, nor is it endorsed by ASH or ASCO.

cancer treatment centers of America®

CTCAREVIEW

Program ChairSyed A. Abutalib, MD Assistant director, stem cell transplant and cell therapy Program cancer treatment centers of America Zion, il

Hematology Course DirectorSyed A. Abutalib, MD

Oncology Course DirectorMaurie Markman, MDsenior vice President of clinical Affairs national director of Medical oncologycancer treatment centers of AmericaPhiladelphia, PA

rEgiSTEr nOw AT

www.ctcareviewcme.org

rEgiSTEr nOw ATwww.ctcareviewcme.org

2013

registration Fees

Saturday, July 13, 2013 The Peninsula Chicago Chicago, Illinois

• Physician(MD/DO):$150.00

•Other(IncludesNursePractitioner,PhysicianAssistant,Nurse,Pharmacist,NaturopathicPhysician,orChiropractor):$75.00

•OncologyorHematologyFellow:Complimentary The conference registration fee includes tuition, continental breakfast,coffeebreaks,lunch,andCME/CEcertificate.Althoughitisnot a Cancer Treatment Centers of America policy to limit registrants for this program, conference room capacity limits may necessitate the closing of enrollment. Confirmation of registration is made on afirst-come,first-servedbasis.ALetterofConfirmationwillbesentonce we receive your completed registration form and payment. This LetterofConfirmationmustbepresentedwhencheckinginattheMeetingRegistrationDesk.

Cancellation PolicyYourregistrationfee,lessa$25administrativefee,willberefundedif written notification is received by Athena Education Group before June15,2013.

Youmayemailyourcancellationrequesttoshiva.noorchashm@athenaedgroup.com.PleaseincludethewordCancellationinthesubjectline.Youmayalsofaxcancellationrequeststo(609)460-4127.NorefundswillbeissuedafterJune15,2013.

Hotel informationThePeninsulaChicagoindowntownChicagowillserveasthelocationforthe2013CTCAREVIEW.ThePeninsulaChicagoisideallylocated in the heart of downtown Chicago, just a short distance from many of Chicago’s sites. The CTCA REVIEW has negotiated a discountedroomratewithThePeninsulaChicago.Pleasemakereservationsdirectlywiththehotel;ablockofroomsisbeingheldforCTCAREVIEWattendeesuntilJune1,2013.Afterthat,reservationswill be based on space availability, and the special room rate may not behonored.Lodgingisatyourownexpense.Toreserveyourroom,contactthehoteldirectlyat:

ThePeninsulaChicago108EastSuperiorStreet(at North Michigan Avenue)Chicago,IL60611Tel(312)337-2888

PleasebesuretorequestthespecialCTCAREVIEWratewhenmakinghotel reservations.

ParkingIfyouaredrivingtotheconference,dailyparkingmaybeavailable atthehotel.TheCTCAREVIEWcannotreimburseparkingfees.

QuestionsPleasecontactShivaNoorchashmviaemailatshiva.noorchashm@athenaedgroup.com for any questions regarding the CTCA REVIEW. Foranyquestionsorinquiriesregardingtravellogisticsandhotelaccommodations,pleasecontactSueWhatleyat(813)469-5082.PleasebesuretomentiontheCTCAREVIEWwhenmakinganyinquiry.

Follow us on Twitter #CTCAreview

PRESORTED FIRST-CLASS MAIL

U.S. POSTAGEPAID

SOUTHAMPTON, PAPERMIT NO. 225

Athena Education group, LLCRiverWalk,BuildingA201SouthMainStreet,Suite15Lambertville,NJ08530

Goalthe goal of the ctcA revieW is to efficiently discuss the most recent clinical advances and trials in the rapidly evolving field of malignant hematology and oncology. this program is unique in addressing the questions and controversies that have emerged from the latest data presented at both the American society of Hematology (AsH) and American society of clinical oncology (Asco) annual conferences.*

Educational ObjectivesAfter attending the ctcA revieW, participants should be able to:• Interpretnewandemergingdata

presented at the AsH and Asco annual conferences*

• Incorporatenewerevidence-based data to assess the care of theirpatientswithcancer

• Incorporateknowledgegainedinto appropriate management strategies to improve outcomes in patientswithcancer

•Utilizecurrentstandardsofcareforpatientswithcancer

“The data becomes more alive when you hear a specialist talk about it … medicine is an art

as much as it is a science.”~ Learner from

CTCA REVIEW 2012

“You learn about how the experts are interpreting the data and how

they apply it in day-to-day practice.”~ Learner from

CTCA REVIEW 2012

“There are a lot of changes going on in oncology now and it’s hard for a generalist

to keep up. I think that’s why it’s helpful to attend the CTCA REVIEW.”

~ Learner from CTCA REVIEW 2012

Saturday, July 13, 2013The Peninsula ChicagoChicago, illinois

CME/CE credits will be available!Complimentary for Oncology or Hematology Fellows!

rEgiSTEr nOw AT

www.ctcareviewcme.org

rEgiSTrATiOn AnD HOTEL inFOrMATiOn ADVAnCES & COnTrOVErSiES in MALignAnT HEMATOLOgy & OnCOLOgy

Keepingupwithnewdataandapplyingthemostup-to-dateinformationhasbeenidentifiedbyhematology and oncology professionals as the biggest challenge today in the treatment of hematologic and oncologic disorders.

the ctcA revieW is an annual continuing medical education (cMe) program designed to provide attendees withasolutiontothischallenge.Featuringafacultyofinternationallyrecognizedexpertsthiscoursehighlightscutting-edgeresearchandclinicalstudiespresentedduringtheAmericanSocietyofHematology(AsH) and American society of clinical oncology (Asco) annual meetings. By combining these highlights withcasestudiesandpatientmanagementscenarios,theCTCAREVIEWwillprovideattendeeswithreliableinformationthatwillassistthemtomakebetterdecisionsfortheirpatients.

ConFEREnCEA

gEndA

AdvAnces & controversies in MAlignAnt HeMAtology & oncology

cancer treatment centers of America®ProgrAM cHAir syed A. Abutalib, Md

CTCAREVIEWSaturday, July 13, 2013︲the Peninsula chicago︲chicago, illinois

AlB.BensonIII,Md,FACPProfessorofMedicineAssociate Director for Clinical InvestigationsRobertH.LurieComprehensiveCancerCenterof Northwestern University Chicago,IL

TimothyM.KuzelMd,FACPDirector,WalterS.andLucienneDriskillImmunotherapyResearchProgramProfessorofMedicineandDermatologyDivisionofHematology/OncologyNorthwesternUniversityFeinbergSchoolofMedicine,Chicago,IL

Kim Margolin, MdProfessor,UniversityofWashingtonMember,FredHutchinsonCancerResearchCenterPhysician,SeattleCancerCareAlliance Seattle,WA

ravi salgia, MdProfessorofMedicine,Pathology&DermatologyDirectorofThoracicOncologyProgram,andAerodigestiveTractProgramTranslationalResearchLaboratoriesVice Chair for Translational ResearchSectionofHematology/Oncology, Department of MedicineUniversityofChicagoMedicalCenter,Chicago,IL

EverettE.Vokes,MdJohnE.UltmannProfessorChairman, Department of MedicinePhysician-in-Chief,UniversityofChicagoMedicineUniversity of Chicago Chicago,IL

onCologyCoURSEdIRECToRMaurieMarkman,MdSeniorVicePresidentofClinicalAffairs NationalDirectorofMedicalOncologyCancer Treatment Centers of AmericaPhiladelphia,PA

William gradishar, MdNorthwesternUniversityFeinberg SchoolofMedicine Chicago,IL

onCologyTRACKFACUlTy

rEgiSTEr nOw AT

www.ctcareviewcme.org

rEgiSTEr nOw AT

www.ctcareviewcme.orgoncology trAcK Course Director – Maurie Markman, MD

Exhibit Hall Open 7:00 am – 6:30 pm

7:00am–7:50am ContinentalBreakfast

7:50am–8:00am openingRemarks MaurieMarkman,MD

8:00am–8:30am HeadandneckCancers EverettE.Vokes,MD

8:30am–9:00am lung cancer RaviSalgia,MD

9:00am–9:30am gynecologic cancersMaurieMarkman,MD

9:30am–10:00am genitourinary cancers TimothyM.KuzelMD,FACP

10:00am–10:15am Break

10:15am–11:00amgi oncology AlB.Benson,III,MD,FACP

11:00am–11:30am SkinCancersKim Margolin, MD

11:30am–12:00pm Breast cancerWilliam Gradishar, MD

HeMAtology trAcK Course Director – Syed A. Abutalib, MD

12:00pm–12:45pmlunch and openingRemarks SyedA.Abutalib,MD

12:45pm–1:15pm Hodgkinlymphoma Istvan Redei, MD

1:15pm–2:00pm non-Hodgkinlymphoma JamesO.Armitage,MD

2:00pm–2:30pm Acuteleukemias FarhadRavandi-Kashani,MD

2:30pm–3:00pm Myelodysplastic syndromes WendyStock,MD

3:00pm–3:15pm Break

3:15pm–3:45pm ChronicMyeloidleukemia JeraldP.Radich,MD

3:45pm–4:15pmMyeloproliferative diseases Ayalew Tefferi, MD

4:15pm–4:45pm Chroniclymphocyticleukemia MichaelJ.Keating,MB,BS

4:45pm–5:20pm Multiple Myeloma AndrzejJ.Jakubowiak,MD,PhD

5:20pm–5:50pm Hematology/oncology & nutrition case discussion CarolynLammersfeld,MS,RD

James o. Armitage, MdTheJoeShapiroProfessorofMedicine UniversityofNebraskaMedicalCenterOmaha,NE

carolyn lammersfeld, Ms, rdVicePresidentofIntegrativeMedicine Cancer Treatment Centers of AmericaZion,IL

WendyStock,MdProfessorofMedicineDirector,LeukemiaProgramUniversity of ChicagoChicago,IL

Jerald radich, MdMember, Clinical Research DivisionFredHutchinsonCancerResearchCenter Seattle,WA

AndrzejJ.Jakubowiak,Md,PhdProfessorofMedicineDirector,MyelomaProgramSectionofHematology/OncologyUniversity of Chicago Medical CenterChicago,IL

istvan redei, Md NationalDirector,StemCellTransplant andCellTherapyProgramCancer Treatment Centers of AmericaZion,IL

Michael J. Keating, MB, BsProfessorofMedicineDepartmentofLeukemia University of Texas MD Anderson Cancer CenterHouston,TX

FarhadRavandi-Kashani,MdProfessorofMedicineDepartmentofLeukemiaUniversity of Texas MD Anderson Cancer CenterHouston,TX

AyalewTefferi,MdProfessorofMedicineandHematologyMayo Clinic Rochester, MN

HEMATologyCoURSEdIRECToRsyed A. Abutalib, Md AssistantDirector,StemCellTransplant andCellTherapyProgramCancer Treatment Centers of AmericaZion,IL

“There is remarkable progress in both solid tumors and blood cancers, and of course the CTCA REVIEW highlights in practical terms these advances in diagnosis, prognosis, and treatment. This is a wonderful

opportunity to meet experts and assure that patients have access to cutting-edge cancer care.”~ Kenneth Anderson MD, CTCA REVIEW 2012 Faculty Member, Dana-Farber Cancer Institute

“Oncology is a community practice, not an academic-centric practice. The CTCA REVIEW

enriches that oncology community with education and clinical research in a completely new paradigm.”

~ Ayalew Tefferi, MD, Faculty Member

“Cancer care gets more complicated all the time so you want to bring this event

together to let the doctors in the community learn and know about best practices.”

~ Maurie Markman, MD Oncology Course Director

“The positive feedback we received from last year’s faculty and attendees on the need for this

type of program, reinforced our decision to host the symposium in 2013.”

~ Syed A. Abutalib, MD, Program Chair

HEMATologyTRACKFACUlTy

rEgiSTEr nOw AT

www.ctcareviewcme.org